No Expiry for Singapore Registrations: Retention Fees and Cancellation Rules

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Singapore medical device registrations have no fixed expiry date. A registration stays on the register for as long as the annual retention fee is paid. Under section 12 of GN-15 R15, the annual retention fee is SGD 39 for Class B, SGD 67 for Class C and SGD 134 for Class D, with Class D devices that contain a registrable medicinal product also at SGD 134. Missing the payment by more than 30 days requires a written explanation to HSA. Missing it by 60 days means the listing is cancelled and import and supply must stop. The fee itself is trivial; the consequence of missing it is not.

  • No expiry, only maintenance. There is no five-year renewal cycle for Singapore registrations, contrary to a common misconception.
  • Three fee levels. SGD 39 for Class B, SGD 67 for Class C, SGD 134 for Class D, including Class D with a registrable medicinal product.
  • Thirty days triggers an explanation. Payment overdue by more than 30 days requires a written statement of reasons to HSA.
  • Sixty days triggers cancellation. At 60 days the listing is cancelled and import and supply must stop.
  • Class A sits outside the system. Class A devices are exempt from product registration, so the product registration retention fee does not apply to them.
  • Two separate calendars. Registration retention and dealer licence renewal are different annual actions with different dates.

2. Legal basis

GN-15 is the Guidance on Medical Device Product Registration. Revision R15, issued in October 2026, contains in section 12 the retention fee mechanism and the cancellation rule that supports it. The section fixes the fee by class, sets the 30 day threshold at which a written explanation becomes necessary, and sets the 60 day threshold at which the listing is cancelled and supply must cease. Because the mechanism is a maintenance obligation rather than a renewal, there is no application to prepare and no technical review to undergo each year: the registrant pays, and the registration continues.

GuidanceGN-15, Guidance on Medical Device Product Registration
Version and dateR15, October 2026
Key sectionSection 12: annual retention fee and cancellation
Annual retention feeClass B SGD 39 / Class C SGD 67 / Class D SGD 134 (Class D with a registrable medicinal product: SGD 134)
Overdue by 30 daysA written statement of reasons must be submitted
Overdue by 60 daysThe listing is cancelled and import and supply must stop
Class AExempt from product registration, so the product registration retention fee mechanism does not apply

3. Expert insights

The absence of an expiry date is a structural difference from most markets, and it is the point most often misstated. A significant proportion of the Chinese-language material we have reviewed describes Singapore registrations as valid for five years or as requiring renewal every five years. That is incorrect. The Singapore mechanism is that a registration, once granted, persists indefinitely for as long as the annual retention fee is paid. Malaysia, by contrast, issues registrations with a five-year validity that must be renewed periodically. Treating the two mechanisms as equivalent creates substantive miscommunication with clients, because it implies a re-registration project that does not exist and obscures the obligation that does.

The fee is very low, but the consequence of missing it is very heavy. An annual cost of SGD 39, SGD 67 or SGD 134 is almost negligible against registration review fees of SGD 3,900 to SGD 12,000. Yet at 60 days overdue the registration listing is cancelled and import and supply must stop. That writes off the entire registration investment and requires a fresh application, with a review of 160 to 310 working days ahead. Measured by consequence rather than by cost, this is the lowest-cost and highest-risk action in the Singapore compliance system, and it deserves to be treated as a critical control rather than as an accounts payable item.

Thirty days and 60 days are different thresholds and should not be conflated. At more than 30 days overdue, a written explanation must be submitted to HSA, and there is still room to recover. At 60 days overdue, the listing is cancelled, import and supply must stop, and there is no recovery other than a new application. The 30 day window in between is the only operating space available, which is why an internal alert well before day 30 is worth more than any amount of escalation after day 60. A payment reminder set at 60 days before the due date gives the finance and regulatory teams enough runway to resolve a dispute over who pays.

The payment obligation sits with the Registrant, but the risk sits with the manufacturer. The annual retention fee is paid by the Registrant, while the party that cannot supply when the registration is cancelled is the manufacturer. This is a textbook separation of responsibility and risk. In licence-holding service agreements drafted for manufacturers, we make payment a verifiable obligation by requiring the Registrant to provide proof of payment each year, and we attach contractual liability to non-payment. Without that, the manufacturer is relying on an annual assurance that it cannot see.

Dealer licence renewal is a different calendar. The two annual actions are easily confused, so it helps to state them side by side. Product registration is maintained by the annual retention fee of SGD 39, SGD 67 or SGD 134 and has no fixed validity. A dealer’s licence has a validity of 12 months and is renewed annually at SGD 1,110. Both must be performed, and their dates are usually different because they start from different events. Managing them in one calendar without distinguishing the two obligations is how one of them gets missed.

4. Practical recommendations

  • Build a payment calendar for every listing. Set the first reminder 60 days before the due date, not 60 days after it.
  • Require proof of payment in the holding agreement. Make the retention fee a verifiable obligation rather than an assurance.
  • Treat day 30 as a red-line event. If payment is late, submit the written explanation immediately rather than waiting for the next quarter.
  • Manage the two calendars separately. Registration retention and dealer licence renewal are distinct obligations with distinct dates.
  • Do not attempt a transfer after cancellation. A cancelled listing must be registered again, at far higher cost than paying on time.

5. Verification checklist

  • □ The class and retention fee for each listing are confirmed at SGD 39, SGD 67 or SGD 134
  • □ A payment calendar exists with reminders 60 days before the due date
  • □ The holding agreement requires annual proof of payment
  • □ Registration retention is distinguished from licence renewal at SGD 1,110 for 12 months
  • □ The different consequences at 30 days and 60 days are understood by the responsible team
  • □ All listings are currently paid and in good standing

Regulatory information verified as of 26 October 2026. Source tiers: secondary (GN-15 R15 section 12, GN-02 R8, HSA fees page).

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail